Lars Skriver
Impact in
- Cancer Research top 0.5%
- Protease and Inhibitor Mechanisms
- Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Protease and Inhibitor Mechanisms 13
-
- Growth Hormone and Insulin-like Growth Factors 6
- Co-authors
- Keld Danø (11 shared papers)Jan Grøndahl-Hansen (7 shared papers)P.A. Andreasen (5 shared papers)Lars Søegaard Nielsen (4 shared papers)Guy A. Thompson (4 shared papers)Peter Kjær Kristensen (2 shared papers)Jesper Zeuthen (5 shared papers)Lars Larsson (2 shared papers)
- Journals
- Biochemistry (3 papers)The EMBO Journal (2 papers)The Journal of Cell Biology (2 papers)FEBS Letters (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- DenmarkUnited StatesGermany
In The Last Decade
Lars Skriver
30 papers receiving 4.1k citations
Lars Skriver's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 2.4k
- Hematology 989
- Biochemistry 113
- Molecular Biology 777
- Immunology and Allergy 52
Countries citing papers authored by Lars Skriver
This map shows the geographic impact of Lars Skriver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Skriver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Skriver more than expected).
Fields of papers citing papers by Lars Skriver
This network shows the impact of papers produced by Lars Skriver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Skriver. The network helps show where Lars Skriver may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Skriver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Plasminogen Activators, Tissue Degradation, and Cancer Hit paper breakdown → | 1985 | 2340 |
| 2 | 1982 | 236 | |
| 3 | 1986 | 218 | |
| 4 | 1988 | 215 | |
| 5 | 1984 | 169 | |
| 6 | 1976 | 159 | |
| 7 | 1984 | 158 | |
| 8 | 1982 | 102 | |
| 9 | 1976 | 100 | |
| 10 | 1979 | 78 | |
| 11 | 1984 | 75 | |
| 12 | 1996 | 63 | |
| 13 | 1983 | 57 | |
| 14 | 1986 | 57 | |
| 15 | 2021 | 51 | |
| 16 | 1985 | 48 | |
| 17 | 1986 | 42 | |
| 18 | 1979 | 39 | |
| 19 | 1993 | 30 | |
| 20 | 1993 | 27 |
About Lars Skriver
Lars Skriver is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism, Molecular Biology, Biochemistry and Hematology, having authored 30 papers that have together received 4.4k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (13 papers), Growth Hormone and Insulin-like Growth Factors (6 papers), Lipid Membrane Structure and Behavior (4 papers), Protein purification and stability (4 papers), Genetic and Kidney Cyst Diseases (2 papers), Lipid metabolism and biosynthesis (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Protist diversity and phylogeny (2 papers). The work is most often cited by research in Cancer Research (2.4k citations), Hematology (989 citations), Biochemistry (113 citations), Molecular Biology (777 citations) and Immunology and Allergy (52 citations). Lars Skriver has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Keld Danø, Jan Grøndahl-Hansen, P.A. Andreasen, Lars Søegaard Nielsen, Guy A. Thompson, Peter Kjær Kristensen, Jesper Zeuthen, Lars Larsson, Yasuo Kitajima and Leif R. Lund. Their work appears in journals such as Biochemistry, The EMBO Journal, The Journal of Cell Biology, FEBS Letters and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.